Development of a peri-implantitis model in the rat
- PMID: 31701561
- DOI: 10.1111/clr.13556
Development of a peri-implantitis model in the rat
Abstract
Objectives: The aim of the present study was to establish a rodent peri-implantitis model induced by a mixed bacterial infection characterized by bone loss and semi-quantitative graduation of peri-implant inflammation in histological sections.
Materials and methods: Two titanium implants were implanted in Sprague-Dawley rats, bilaterally in each maxilla. After 3 weeks healing, the rats were randomized into three groups according to different treatments over the next 3 months: Antibiotic-Group with oral lavage of antibiotics; Bacteria-Group with oral lavage of Streptococcus oralis and Aggregatibacter actinomycetemcomitans; and Untreated Group with standard housing and no additional treatment. Maxillae were dissected to perform microscopic and histological analysis of bone height and peri-implant tissues.
Results: The bone level, measured at one implant site per animal, in the Bacteria-Group (2.60 ± 0.39 mm) was significantly reduced compared to the Antibiotic-Group (2.29 ± 0.32 mm) after 3 months. The differences of bone height in the Bacteria-Group and the Untreated Group (2.46 ± 0.27 mm) did not reach statistical significance. The inflammatory response with respect to the number of inflammatory cells and fibrous tissue compartments of the peri-implant tissues in the Bacteria-Group was significantly increased compared with the Antibiotic-Group (p < .05). S. oralis and A. actinomycetemcomitans DNAs were detected in the Bacteria-Group.
Conclusions: This rat model of peri-implantitis used oral bacterial lavage for the induction of an inflammatory host response and bone loss. Additional bacterial treatment enhances the peri-implant phenotype, so that significant differences to a reduced bacterial load similar to the human peri-implantitis disease can be identified.
Keywords: Aggregatibacter actinomycetemcomitans; Streptococcus oralis; dental implants; peri-implantitis; rat model; rats.
© 2019 The Authors. Clinical Oral Implants Research published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Alani, A., & Bishop, K. (2014). Peri-implantitis. Part 3: Current modes of management. British Dental Journal, 217(7), 345-349. https://doi.org/10.1038/sj.bdj.2014.858
-
- Baker, P. J., Dixon, M., & Roopenian, D. C. (2000). Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infection and Immunity, 68(10), 5864-5868. https://doi.org/10.1128/IAI.68.10.5864-5868.2000
-
- Baker, P. J., Evans, R. T., & Roopenian, D. C. (1994). Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Archives of Oral Biology, 39(12), 1035-1040. https://doi.org/10.1016/0003-9969(94)90055-8
-
- Becker, S. T., Foge, M., Beck-Broichsitter, B. E., Gavrilova, O., Bolte, H., Rosenstiel, P., & Wiltfang, J. (2013). Induction of periimplantitis in dental implants. Journal of Craniofacial Surgery, 24(1), e15-e18. https://doi.org/10.1097/SCS.0b013e318266fb2d
-
- Berglundh, T., Gislason, O., Lekholm, U., Sennerby, L., & Lindhe, J. (2004). Histopathological observations of human periimplantitis lesions. Journal of Clinical Periodontology, 31(5), 341-347. https://doi.org/10.1111/j.1600-051X.2004.00486.x
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources